Generated Narrative: PlanDefinition

CQF Knowledge capability: shareable

CQF Knowledge capability: computable

CQF Knowledge capability: publishable

CQF knowledge representation level: structured

StructureDefinition Work Group: cds

url: http://hl7.org/fhir/uv/cpg/PlanDefinition/cc-cpg-plan-ckd

version: 2.0.0-ballot

name: ChronicKidneyDiseaseAmbulatory

title: Chronic Kidney Disease - Ambulatory Plan Definition

type: Order Set (PlanDefinitionType#order-set)

status: active

experimental: true

date: 2023-12-19 19:53:17+0000

publisher: HL7 International / Clinical Decision Support

contact: HL7 International / Clinical Decision Support: http://www.hl7.org/Special/committees/dss

description: Chronic Kidney Disease - Ambulatory

UseContexts

jurisdiction: World (m49.htm#001)

copyright: Copyright © Elsevier, and others.

topic: Treatment (DefinitionTopic#treatment)

relatedArtifact

type: justification

display: SYNOPSIS - Chronic Kidney Disease KEY POINTS Decline in function of the kidney characterized by at least 3 months of reduced GFR (less than 60 mL/minute/ 1.73 m²) or at least 3 months of structural or functional kidney damage Assessment of both GFR and albuminuria is necessary to diagnose chronic kidney disease and monitor disease progression GFR is most commonly estimated through measuring serum creatinine and the use of GFR estimating equations, either the Modification of Diet in Renal Disease Study equation or the Chronic Kidney Disease Epidemiology Collaboration equation Albuminuria is measured by urine albumin/creatinine ratio; greater than 30 mg/g indicates albuminuria Chronic kidney disease is commonly associated with hypertension, diabetes, and cardiovascular disease First line therapy includes ACE inhibitors and/or angiotensin II receptor blockers to reduce albuminuria and hypertension If left untreated, chronic kidney disease can progress to end-stage renal disease requiring dialysis or renal transplant Symptoms of end-stage renal disease (eg, pruritus, refractory electrolyte imbalances, metabolic acidosis, severe nausea, neurologic impairments) typically occur when GFR is 5 to 10 mL/minute/1.73 m² Carefully monitor electrolyte levels, hemoglobin, parathyroid hormone levels, and sodium bicarbonate levels to detect complications of chronic kidney disease, including cardiovascular disease, anemia, bone mineral disease, and metabolic acidosis URGENT ACTION Hyperkalemia may require urgent treatment in patients being treated for chronic kidney disease Urgent treatment consists of calcium chloride or calcium gluconate and regimens of sodium bicarbonate, glucose and insulin, or nebulized albuterol PITFALLS Early stages are often asymptomatic, causing chronic kidney disease to be untreated, leading to further progression of kidney damage and worse prognosis

citation: Chronic Kidney Disease Clinical Overview. ClinicalKey. Source

url: http://himss19.ordersetsmanager.com/evidenceviewer/#/7CBBBE9B75E10232E05352E3610A5325/7CBBBE9B75E10232E05352E3610A5325

document

action

id

cc-cpg-activity-referral-nephrology

title: Referrals

groupingBehavior: visual-group

action

id

34387224

title: Referral: Nephrology; History: [add diagnosis, symptom(s)]; Question: [add reason for referral]

description: Referrals

requiredBehavior: could

precheckBehavior: no

definition: Referral: Nephrology; History: [add diagnosis, symptom(s)]; Question: [add reason for referral]

action

id

cc-cpg-activity-referral-dietition

title: Referral: Dietitian; History: chronic kidney disease; Question: [add reason for referral]

description: Referrals

requiredBehavior: could

precheckBehavior: no

definition: Referral: Dietitian; History: chronic kidney disease; Question: [add reason for referral]